MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|120|5|675-682

ISSN: 0008-543x

Source: CANCER, Vol.120, Iss.5, 2014-03, pp. : 675-682

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract